News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Dunne’s medicinal cannabis list will not help patients

Press release: Dunne’s medicinal cannabis list will not help patients, says NORML

[23 Feb 2017]

Dunne’s latest announcement will make little difference to patients and is merely a smokescreen to hide the Government’s lack of action, says NORML.

In a press release, Peter Dunne is trumpeting the fact that he’s written to medical organisations to share a list of overseas cannabis products and tell doctors to consider cannabis products with an “open mind”. Ironically, the content of his message to doctors shows the ones with the most closed minds on the topic reside in his own government office.

“Unfortunately this won’t make much difference,” said Chris Fowlie, president of NORML NZ Inc. “The real problems remain: the lack of funding, and the complicated burdensome application process that puts off patients and doctors from even applying.”

“All medicinal cannabis products remain unfunded by Pharmac, so they are still out of reach of most patients. Moreover, the products on Dunne’s list are only available to a tiny number of patients who make it through the Ministry of Health’s ridiculously arduous application process,” said Rebecca Reider, board member and first to legally possess herbal medicinal cannabis.

For example, Sativex costs around $1100 to $1400 per month, depending on each pharmacy’s profit margin. Bedrocan and Tilray, the other two overseas natural cannabis products listed, will also be too expensive for most patients to afford.

In his press release, Peter Dunne agreed Sativex is too expensive: “Unfortunately, Sativex, the one pharmaceutical-grade product that is available in New Zealand continues to be extortionately priced as big pharma continues to ignore the building resentment, both local and global, to the attitude these companies take to the sick and vulnerable.”

“It’s a slap in the face to all patients that Mr Dunne is blaming ‘big pharma’ and saying their extortionist pricing and bad attitudes are to blame. The real problem is the attitudes of Dunne and the National Party, who seem to think that cannabis is only a medicine when it’s patented by an overseas company,” said Rebecca Reider. “Why do we need a foreign corporation to press it into a hyper-expensive form for us? We have all the tools to grow and produce cannabis medicine right here in New Zealand.”

Peter Dunne recently criticised patients who protested near his home, saying “I actually don’t think any of those people were genuinely concerned about the people who were suffering, they were thinking about their own selfish agendas.”

“Under Peter Dunne’s watch patients have died waiting for approvals. It’s no wonder they are desperate and angry,” said Chris Fowlie. “There are plenty of things Peter Dunne and the National Party could easily do to facilitate safe legal access to medicinal cannabis, if they really wanted to.”

- ends –

Peter Dunne's press release is at http://www.scoop.co.nz/stories/PA1702/S00290/options-and-expectations-for-cannabis-based-products.htm.
For more information including what Peter Dunne and the National Party should be doing, please see: https://norml.org.nz/2017/dunnes-medicinal-cannabis-list-makes-little-difference-says-norml/


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Review: Howard Davis On Olivier Assayas' 'Personal Shopper'

Olivier Assayas’ Personal Shopper is stylish, mysterious, and very strange indeed. It manages to be both ghost story and suspense thriller, yet also a portrait of numbed loneliness and ennui , held together by an peculiarly inexpressive performance from ... More>>

Howard Davis: Never Too Old To Rock & Roll - Jethro Tull

As Greil Marcus recently observed in an NYRB review of Robbie Robertson's autobiographical Testimony, in rock and roll there is always an origin story. In the case of Jethro Tull founder Ian Anderson, he claims to have been influenced by his father's big band and jazz record collections and the emergence of rock music in the 1950s, but became disenchanted with the "show biz" style of early US stars like Elvis Presley... More>>

October: Alice Cooper Returns To NZ

It was March 1977 when Alice Cooper undertook his first ever concert tour of New Zealand – and broke attendance records. 40 years on and this revered entertainer continues to surprise and exude danger at every turn, thrilling audiences globally! More>>

ALSO:

Howard Davis Review: The Contemporary Relevance Of Denial

Denial has all the hallmarks of a riveting courtroom drama. Based on a 1996 British libel case that author David Irving brought against Lipstadt, the movie has been criticized as flat and stagey, but it nonetheless conveys a visceral clarity of vision and sense of overwhelming urgency. More>>

Obituary: John Clarke Dies Aged 68

Andrew Little: “I grew up with Fred Dagg and I am devastated by John Clarke’s death. He taught us to laugh at ourselves and more importantly laugh at our politicians.” More>>

ALSO:

Howard Davis: Colin McCahon's 'on Going Out With The Tide'

Curated by Wystan Curnow and Robert Leonard, On Going Out with the Tide features major works that have been assembled from public and private collections across New Zealand and Australia. It focusses on McCahon’s evolving engagement with Māori subjects and themes, ranging from early treatments of koru imagery to later history paintings which refer to Māori prophets and investigate land-rights issues. More>>

Howard Davis: Rodger Fox Gets Out The Funk

By now a living New Zealand legend, band leader and trombonist Rodger Fox has performed with some of the biggest names in the jazz business, including Louie Bellson, Bill Reichenbach, Chuck Findley, Randy Crawford, Bobby Shew, Lanny Morgan, Bruce Paulson, Diane Schuur, Arturo Sandoval, David Clayton-Thomas, and Joe Williams, to name only a few. More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news